Completed PHASE1 INTERVENTIONAL 5-arm NCT00179023

The Autonomic Nervous System and Obesity

Sponsor: Vanderbilt University

Conditions HYPERTENSION OBESITY PURE AUTONOMIC FAILURE SHY-DRAGER SYNDROME

Interventions Pseudoephedrine Trimethaphan

Updated 6 times since 2017 Last updated: Feb 27, 2018 Started: Apr 30, 2003 Primary completion: Jan 31, 2017 Completion: Jan 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on HYPERTENSION and OBESITY, this trial is completed. The trial is conducted by Vanderbilt University and has accumulated 6 data snapshots since 2003. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed · Phase: PHASE1_PHASE2 → PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE1_PHASE2

First recorded

Apr 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Vanderbilt University

Data source: Vanderbilt University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nashville, United States